Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDA10 (epoetin alfa) vs Eprex in anemia of chronic renal failure
KCT0006024Phase 3Completed
- Sponsor
- Pangen Biotech Inc.
- Start
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Erisa in anaemia, sponsored by Pangen Biotech Inc.. Started Oct 2013; status: completed.
02
Drugs
Erisa
03
Conditions
anaemia
Beyond the preview
Go deeper on KCT0006024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006024.